SCHEMBL6785489

SCHEMBL6785489

CC(C)(C)OC(=O)N1CCN(C(=O)OC(C)(C)C)C2C(=O)N(Cc3ccccc3)C(=O)C21

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
STS P08842 1/20 0.46
NR1H2 P55055 2/20 0.44
NR1H3 Q13133 2/20 0.44
ALDH1A1 P00352 5/20 0.43
GPR119 Q8TDV5 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
GAA P10253 1/20 0.42
CYP2C9 P11712 1/20 0.42
HPGD P15428 1/20 0.42
CYP2C19 P33261 1/20 0.42
STAT6 P42226 1/20 0.42
TSHR P16473 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18453229 0.89 ALDH1A1 (0.48) KMT2AMEN1STSALDH1A1GPR119
SCHEMBL29043064 0.87 ALDH1A1 (0.52) KMT2AMEN1STSALDH1A1GPR119
SCHEMBL28711388 0.87 ALDH1A1 (0.52) KMT2AMEN1STSALDH1A1GPR119
SCHEMBL29043063 0.87 ALDH1A1 (0.52) KMT2AMEN1STSALDH1A1GPR119
SCHEMBL7969208 0.80 CACNA1G (0.47) KMT2ASTSNR1H2NR1H3ALDH1A1
SCHEMBL7969204 0.80 CACNA1G (0.47) KMT2ASTSNR1H2NR1H3ALDH1A1
SCHEMBL6785103 0.78 NR1H2 (0.47) KMT2ASTSNR1H2NR1H3GPR119
SCHEMBL15271240 0.77 GPR119 (0.44) KMT2ASTSNR1H2NR1H3GPR119
SCHEMBL15289827 0.77 GPR119 (0.44) KMT2ASTSNR1H2NR1H3GPR119
SCHEMBL6975743 0.77 NR1H2 (0.48) NR1H2NR1H3GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6828316-B2 Antiallergens KOWA CO., LTD. (JP) 2004-12-07 US disclosed
US-20020042414-A1 Diamide compound and medicine containing the same KOWA CO., LTD. (JP) 2002-04-11 US disclosed
US-6340682-B1 FOR THERAPY OF ALLERGIC IMMUNOLOGICAL DISEASE IS SELECTED FROM ASTHMA, ALLERGIC RHINITIS, INFLAMMATORY LARGE BOWEL DISEASE OR CONTACT DERMATITIS KOWA CO., LTD. (JP) 2002-01-22 US disclosed
EP-0926138-A1 DIAMIDE COMPOUNDS AND DRUGS CONTAINING THE SAME KOWA CO. LTD. (JP) 1999-06-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020042414-A1 Diamide compound and medicine containing the same HRH4, HRH2, HRH1 KMT2A 439/4885MEN1 3292/4885STS 4750/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.